Impact of FKS1 Genotype on Echinocandin In Vitro Susceptibility in Candida auris and In Vivo Response in a Murine Model of Infection

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · see citing works

How to calculate sample size in animal studies?

Charan, J., & Kantharia, N. D. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.119726 · Cited by 1,881 · see citing works

Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · see citing works

<i>Candida auris</i> sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital

Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · see citing works

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298 · see citing works

First hospital outbreak of the globally emerging Candida auris in a European hospital

Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance &amp; Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768 · see citing works

Candida auris: a Review of the Literature

Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K. J., Johnson, E. M., Borman, A. M., Candida auris Incident Management Team, Manuel, R. J., & Brown, C. S. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-17 · Cited by 610 · see citing works

A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

Chowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577 · see citing works

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

Arendrup, M. C., Boekhout, T., Akova, M., Meis, J. F. G. M., Cornely, O. A., & Lortholary, O. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12360 · Cited by 533 · see citing works

A <i>Candida auris</i> Outbreak and Its Control in an Intensive Care Setting

Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517 · see citing works

Tracing the evolutionary history and global expansion of <i>Candida auris</i> using population genomic analyses

Chow, N. A., Muñoz, J. F., Gade, L., Berkow, E., Li, X., Welsh, R. M., Forsberg, K., Lockhart, S. R., Adam, R., Alanio, A., et al. (2020) · doi:10.1101/2020.01.06.896548 · Cited by 463 · see citing works

Incidence, characteristics and outcome of ICU-acquired candidemia in India

Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454 · see citing works

Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins

Walker, L. A., Munro, C. A., de Bruijn, I., Lenardon, M. D., McKinnon, A., & Gow, N. A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000040 · Cited by 445 · see citing works

Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System

Turenne, C. Y., Sanche, S. E., Hoban, D. J., Karlowsky, J. A., & Kabani, A. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1846-1851.1999 · Cited by 435 · see citing works

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · see citing works

Candida auris: an Emerging Fungal Pathogen

Spivak, E. S., & Hanson, K. E. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01588-17 · Cited by 393 · see citing works

Echinocandin resistance in Candida.

Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374 · see citing works

Candida auris candidaemia in Indian ICUs: analysis of risk factors

Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357 · see citing works

Current Perspectives on Echinocandin Class Drugs

Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274 · see citing works

Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values

Arendrup, M. C., Prakash, A., Meletiadis, J., Sharma, C., & Chowdhary, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00485-17 · Cited by 270 · see citing works

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-18 · Cited by 247 · see citing works

Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions

Biswal, M., Rudramurthy, S. M., Jain, N., Shankarnarayan, S. A., Sharma, D., Jain, K., Yaddanapudi, L. N., & Chakrabarti, A. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.09.009 · Cited by 224 · see citing works

Molecular Epidemiology of <i>Candida auris</i> in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance

Escandón, P., Chow, N. A., Caceres, D. H., Gade, L., Berkow, E. L., Armstrong, P., Rivera, S., Misas, E., Duarte, C., Moulton-Meissner, H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy411 · Cited by 222 · see citing works

Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance

Carolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211 · cited 1× · see citing works

Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin Susceptibility

Katiyar, S. K., Pfaller, M. A., & Edlind, T. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-06 · Cited by 189 · see citing works

Invasive candidiasis in critical care: challenges and future directions

Logan, C., Martin-Loeches, I., & Bicanic, T. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06240-x · Cited by 180 · see citing works

FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia

Beyda, N. D., John, J., Kilic, A., Alam, M. J., Lasco, T. M., & Garey, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu407 · Cited by 174 · see citing works

Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned

Zhu, Y., O’Brien, B., Leach, L., Clark, A., Bates, M., Adams, E. H., Ostrowsky, B. E., Quinn, M., Dufort, E. M., Southwick, K. L., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01503-19 · Cited by 166 · see citing works

Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

Ben-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir351 · Cited by 162 · see citing works

Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance

Katiyar, S. K., Alastruey-Izquierdo, A., Healey, K. R., Johnson, M. E., Perlin, D. S., & Edlind, T. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00813-12 · Cited by 148 · see citing works

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections

Ghosh, A. K., Paul, S., Sood, P., Rudramurthy, S. M., Rajbanshi, A., Jillwin, T. J., & Chakrabarti, A. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.11.009 · Cited by 128 · see citing works

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris

Berkow, E. L., & Lockhart, S. R. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.10.021 · Cited by 110 · see citing works

Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast

Kean, R., Brown, J. L., Gülmez, D., Ware, A., & Ramage, G. (2020) · Journal of Fungi · doi:10.3390/jof6010030 · Cited by 86 · see citing works

Determination of chitin content in fungal cell wall: An alternative flow cytometric method

Costa‐de‐Oliveira, S., Silva, A. P., Miranda, I. M., Salvador, A., Azevedo, M. M., Munro, C. A., Rodrigues, A. G., & Pina‐Vaz, C. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22250 · Cited by 68 · see citing works

Retrospective analysis of the clinical characteristics of Candida auris infection worldwide from 2009 to 2020

Hu, S., Zhu, F., Jiang, W., Wang, Y., Quan, Y., Zhang, G., Gu, F., & Yang, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.658329 · Cited by 64 · see citing works

Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1

Ramachandran, R., Shrivastava, M., Narayanan, N. N., Thakur, R. L., Chakrabarti, A., & Roy, U. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01457-17 · Cited by 48 · see citing works

SCY-078, a Novel Fungicidal Agent, Demonstrates Distribution to Tissues Associated with Fungal Infections during Mass Balance Studies with Intravenous and Oral [ 14 C]SCY-078 in Albino and Pigmented Rats

Wring, S. A., Borroto–Esoda, K., Solon, E. G., & Angulo, D. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02119-18 · Cited by 45 · see citing works

In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris

Rudramurthy, S. M., Colley, T., Abdolrasouli, A., Ashman, J., Dhaliwal, M., Kaur, H., Armstrong-James, D., Strong, P., Rapeport, G., Schelenz, S., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz280 · Cited by 44 · see citing works

Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects

Balish, E., WARNER, T. F. C. S., Pierson, C., Bock, D. M., & Wagner, R. D. (2001) · Medical Mycology · doi:10.1080/mmy.39.3.261.268 · Cited by 42 · see citing works

Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin

Imtiaz, T., Lee, K. K., Munro, C. A., MacCallum, D. M., Shankland, G. S., Johnson, E. M., MACGREGOR, M. S., & Bal, A. M. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045047-0 · Cited by 32 · see citing works

Short-term evolution strategies for host adaptation and drug escape in human fungal pathogens

Beekman, C. N., & Ene, I. V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008519 · Cited by 30 · see citing works

Molecular mechanisms governing antifungal drug resistance

Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304 · see citing works

The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris

Rybak, J. M., Cuomo, C. A., & David Rogers, P. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102208 · Cited by 113 · see citing works

Whole genome sequencing analysis demonstrates therapy‐induced echinocandin resistance in <i>Candida auris</i> isolates

Spruijtenburg, B., Ahmad, S., Asadzadeh, M., Alfouzan, W., Al‐Obaid, I., Mokaddas, E., Meijer, E. F. J., Meis, J. F., & de Groot, T. (2023) · Mycoses · doi:10.1111/myc.13655 · Cited by 61 · see citing works

Molecular characterisation of <i>Candida auris</i> isolates from immunocompromised patients in a tertiary‐care hospital in Kuwait reveals a novel mutation in <i>FKS1</i> conferring reduced susceptibility to echinocandins

Asadzadeh, M., Mokaddas, E., Ahmad, S., Abdullah, A. A., de Groot, T., Meis, J. F., & Shetty, S. A. (2022) · Mycoses · doi:10.1111/myc.13419 · Cited by 55 · see citing works

In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022

Codda, G., Willison, E., Magnasco, L., Morici, P., Giacobbe, D. R., Mencacci, A., Marini, D., Mikulska, M., Bassetti, M., Marchese, A., et al. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.14.2300161 · Cited by 44 · see citing works

Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to Candida auris Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of FKS1

Al-Obaid, I., Asadzadeh, M., Ahmad, S., Alobaid, K., Alfouzan, W., Bafna, R., Emara, M., & Joseph, L. (2022) · Journal of Fungi · doi:10.3390/jof8030267 · Cited by 39 · see citing works

Psychogenetic, genetic and epigenetic mechanisms in Candida auris: Role in drug resistance

Rabaan, A. A., Eljaaly, K., Alfouzan, W. A., Mutair, A. A., Alhumaid, S., Alfaraj, A. H., Aldawood, Y., Alsaleh, A. A., Albayat, H., Azmi, R. A., et al. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.12.012 · Cited by 14 · see citing works

Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris

Dudiuk, C., Berrío, I., Leonardelli, F., Morales-López, S. E., Theill, L., Macedo, D., Rodríguez, J. Y., Salcedo, S., Marín, A., Gamarra, S. P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz178 · Cited by 47 · see citing works

Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes

Song, J., & Stevens, D. A. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1068271 · Cited by 62 · see citing works

Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates

Walraven, C. J., Bernardo, S. M., Wiederhold, N. P., & Lee, S. A. (2013) · Medical Mycology · doi:10.1093/mmy/myt007 · Cited by 24 · see citing works

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum

Kovács, R., Tóth, Z., Locke, J. B., Forgács, L., Kardos, G., Nagy, F., Borman, A. M., & Majoros, L. (2021) · Microorganisms · doi:10.3390/microorganisms9040863 · Cited by 43 · see citing works

Adaptation of the emerging pathogenic yeast Candida auris to high caspofungin concentrations correlates with cell wall changes

Lara‐Aguilar, V., Rueda, C., García-Barbazán, I., Varona, S., Monzón, S., Jiménez, P., Cuesta, I., Zaballos, Á., & Zaragoza, Ó. (2021) · Virulence · doi:10.1080/21505594.2021.1927609 · Cited by 40 · see citing works